Ravi Salgia to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Ravi Salgia has written about Drug Evaluation, Preclinical.
Connection Strength
0.067
-
RNA-based therapies: A cog in the wheel of lung cancer defense. Mol Cancer. 2021 03 19; 20(1):54.
Score: 0.049
-
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol. 2008 Apr; 61(4):549-58.
Score: 0.019